Eli Lilly (NYSE:LLY) recently announced leadership transitions, including new roles for Ilya Yuffa, Patrik Jonsson, and ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Eli Lilly’s expanding US production and advancing pipeline offset near-term headwinds and support bullish conviction. Read ...

Eli Lilly (NYSE:LLY) experienced an 11% share price increase over the past month, largely influenced by the affirmation of a $1.50 per share dividend declared for the second quarter. The announcement ...

Trump's Department of Commerce is looking into what it calls national security threats from overseas drug manufacturing, and ...

Eli Lilly & Co has experienced a significant stock price drop of 10.58% over the past week, despite delivering impressive first-quarter results for 2025. The company’s revenue s ...

RHHBY unveiled plans to invest over $700 million in a new 700,000-square-foot, state-of-the-art drug manufacturing facility ...

Eli Lilly (LLY) is among the list of large-cap pharmaceutical ... Meanwhile, the moves are threatening to weaken Europe's R&D and manufacturing strength, prompting executives like AstraZeneca's ...